✦ LIBER ✦
437 Biomarker Development for the Pharmacodynamic Assessment of CC-223, a Potent and Selective mTOR Kinase Inhibitor, in Phase I Clinical Trials
✍ Scribed by Wong, L.; Liu, Y.; Wu, X.; Bauer, D.; Chen, B.; Hege, K.; Chopra, R.; Bendell, J.; Munster, P.; Xu, S.
- Book ID
- 121894177
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 60 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.